DEVELOPMENT OF AN SRF INHIBITOR PEPTIDE FOR THE TREATMENT OF CARDIAC FIBROSIS
By Melissa Herschkowitz, Erika Lisabeth & 1 more. Approximately 18.6 million deaths worldwide attributed to cardiovascular disease (CVD) in 2019; US alone the estimated direct and indirect cost of CVD for 2016 to 2017 was $363 billion.
Authors
- Richard R. Neubig (ORCID: https://orcid.org/0000-0003-0501-0008)
- Erika M. Lisabeth (ORCID: https://orcid.org/0000-0002-4560-3345)
- Melissa Herschkowitz
Institutions
- Michigan State University (US)
Publication Details
- Journal
- Spartan Medical Research Journal
- Published
- 2024-08-30
- DOI
- https://doi.org/10.51894/001c.122796
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00